{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:31:00Z","timestamp":1782275460056,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10067-022-06384-9","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T15:06:21Z","timestamp":1663945581000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recurrent macrophage activation syndrome due to hyperimmunoglobulin D syndrome: a case-based review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4823-2076","authenticated-orcid":false,"given":"Deniz","family":"Gezgin Y\u0131ld\u0131r\u0131m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-9944","authenticated-orcid":false,"given":"\u00c7isem","family":"Y\u0131ld\u0131z Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5038-7539","authenticated-orcid":false,"given":"Nihal","family":"Kara\u00e7ay\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9493-9355","authenticated-orcid":false,"given":"Pelin","family":"Esmeray \u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-2341","authenticated-orcid":false,"given":"Emine Nur","family":"Sunar Yayla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6530-9672","authenticated-orcid":false,"given":"Sevcan A.","family":"Bakkalo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"6384_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-016-0091-7","volume":"14","author":"S Zhang","year":"2016","unstructured":"Zhang S (2016) Natural history of mevalonate kinase deficiency: a literature review. Pediatr Rheumatol Online J 14:30. https:\/\/doi.org\/10.1186\/s12969-016-0091-7","journal-title":"Pediatr Rheumatol Online J"},{"key":"6384_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/9696","volume":"22","author":"JP Drenth","year":"1999","unstructured":"Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckman JS, van der Meer JW, Delpech M (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 22:178\u2013181. https:\/\/doi.org\/10.1038\/9696","journal-title":"Nat Genet"},{"key":"6384_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12016-016-8537-8","volume":"54","author":"D Rigante","year":"2018","unstructured":"Rigante D, Frediani B, Cantarini L (2018) A comprehensive overview of the hereditary periodic fever syndromes. Clin Rev Allergy Immunol 54:446\u2013453. https:\/\/doi.org\/10.1007\/s12016-016-8537-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"6384_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","volume":"87","author":"van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group","year":"2008","unstructured":"van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87:301\u2013310. https:\/\/doi.org\/10.1097\/MD.0b013e318190cfb7","journal-title":"Medicine (Baltimore)"},{"key":"6384_CR5","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","volume":"74","author":"NM ter Haar","year":"2015","unstructured":"ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA et al (2015) Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis 74:1636\u20131644. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207546","journal-title":"Ann Rheum Dis"},{"key":"6384_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00296-006-0164-x","volume":"27","author":"D Rigante","year":"2006","unstructured":"Rigante D, Ansuini V, Bertoni B, Pugliese AL, Avallone L, Federico G, Stabile A (2006) Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome. Rheumatol Int 27:97\u2013100. https:\/\/doi.org\/10.1007\/s00296-006-0164-x","journal-title":"Rheumatol Int"},{"key":"6384_CR7","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/art.11218","volume":"48","author":"K Takada","year":"2003","unstructured":"Takada K, Aksentijevich I, Mahadevan V, Dean JA, Kelley RI, Kastner DL (2003) Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 48:2645\u20132651. https:\/\/doi.org\/10.1002\/art.11218","journal-title":"Arthritis Rheum"},{"key":"6384_CR8","doi-asserted-by":"publisher","first-page":"619257","DOI":"10.3389\/fimmu.2020.619257","volume":"11","author":"H Malcova","year":"2021","unstructured":"Malcova H, Strizova Z, Milota T, Striz I, Sediva A, Cebecauerova D, Horvath R (2021) IL-1 Inhibitors in the treatment of monogenic periodic fever syndromes: from the past to the future perspectives. Front Immunol 11:619257. https:\/\/doi.org\/10.3389\/fimmu.2020.619257","journal-title":"Front Immunol"},{"key":"6384_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bjh.14144","volume":"174","author":"E Brisse","year":"2016","unstructured":"Brisse E, Matthys P, Wouters CH (2016) Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol 174:175\u2013187. https:\/\/doi.org\/10.1111\/bjh.14144","journal-title":"Br J Haematol"},{"key":"6384_CR10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00296-016-3545-9","volume":"36","author":"S Aytac","year":"2016","unstructured":"Aytac S, Batu ED, Unal S et al (2016) Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int 36:1421\u20131429. https:\/\/doi.org\/10.1007\/s00296-016-3545-9","journal-title":"Rheumatol Int"},{"key":"6384_CR11","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/1756-185X.13649","volume":"22","author":"K Barut","year":"2019","unstructured":"Barut K, Adrovic A, Sahin S, Tarcin G, Tahaoglu G, Koker O, Yildiz M (2019) Kasapcopur O (2019) Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: a single-center experience. Int J Rheum Dis 22:1661\u20131669. https:\/\/doi.org\/10.1111\/1756-185X.13649","journal-title":"Int J Rheum Dis"},{"key":"6384_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/children9050672","volume":"9","author":"G Bossi","year":"2022","unstructured":"Bossi G, Codazzi AC, Vinci F, Clerici E, Regalbuto C, Crapanzano C, Veraldi D, Moiraghi A, Marseglia GL (2022) Efficacy of anakinra on multiple coronary arteries aneurysms in an infant with recurrent Kawasaki disease, complicated by macrophage activation syndrome. Children (Basel) 9:672. https:\/\/doi.org\/10.3390\/children9050672","journal-title":"Children (Basel)"},{"issue":"3 Suppl 77","key":"6384_CR13","first-page":"99","volume":"31","author":"G Horneff","year":"2013","unstructured":"Horneff G, Rhouma A, Weber C, Lohse P (2013) Macrophage activation syndrome as the initial manifestation of tumour necrosis factor receptor 1-associated periodic syndrome (TRAPS). Clin Exp Rheumatol 31(3 Suppl 77):99\u2013102","journal-title":"Clin Exp Rheumatol"},{"key":"6384_CR14","doi-asserted-by":"publisher","unstructured":"\u00c7a\u011flayan \u015e, Ulu K, \u00c7akan M, S\u00f6zeri B (2022) A rare onset in tumor necrosis factor receptor-associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection. Rheumatology (Oxford). Jun 22:keac362. https:\/\/doi.org\/10.1093\/rheumatology\/keac362","DOI":"10.1093\/rheumatology\/keac362"},{"key":"6384_CR15","doi-asserted-by":"publisher","first-page":"e29461","DOI":"10.1002\/pbc.29461","volume":"69","author":"VV Iyengar","year":"2022","unstructured":"Iyengar VV, Chougule A, Gowri V, Taur P, Prabhu S, Bodhanwala M, Desai MM (2022) DADA2 presenting as nonimmune hemolytic anemia with recurrent macrophage activation syndrome. Pediatr Blood Cancer 69:e29461. https:\/\/doi.org\/10.1002\/pbc.29461","journal-title":"Pediatr Blood Cancer"},{"key":"6384_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.22409","volume":"56","author":"D Rigante","year":"2007","unstructured":"Rigante D, Capoluongo E, Bertoni B, Ansuini V, Chiaretti A, Piastra M, Pulitan\u00f2 S, Genovese O, Compagnone A, Stabile A (2007) First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum 56:658\u2013661. https:\/\/doi.org\/10.1002\/art.22409","journal-title":"Arthritis Rheum"},{"key":"6384_CR17","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s10067-018-4095-1","volume":"37","author":"HE S\u00f6nmez","year":"2018","unstructured":"S\u00f6nmez HE, Demir S, Bilginer Y, \u00d6zen S (2018) Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature. Clin Rheumatol 37:3329\u20133335. https:\/\/doi.org\/10.1007\/s10067-018-4095-1","journal-title":"Clin Rheumatol"},{"key":"6384_CR18","first-page":"53","volume":"10","author":"A Stabile","year":"2006","unstructured":"Stabile A, Bertoni B, Ansuini V, La Torraca I, Sall\u00ec A, Rigante D (2006) The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur Rev Med Pharmacol Sci 10:53\u201359","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6384_CR19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/acr.22527","volume":"67","author":"GS Schulert","year":"2014","unstructured":"Schulert GS, Bove K, McMasters R, Campbell K, Leslie N, Grom AA (2014) Mevalonate kinase deficiency associated with recurrent liver dysfunction, macrophage activation syndrome and perforin gene polymorphism. Arthritis Care Res (Hoboken) 67:1173\u20131179. https:\/\/doi.org\/10.1002\/acr.22527","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6384_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1542\/peds.2010-3639","volume":"128","author":"B Bader-Meunier","year":"2011","unstructured":"Bader-Meunier B, Florkin B, Sibilia J et al (2011) Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 128:152\u2013159. https:\/\/doi.org\/10.1542\/peds.2010-3639","journal-title":"Pediatrics"},{"key":"6384_CR21","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/art.39763","volume":"68","author":"NM Ter Haar","year":"2016","unstructured":"Ter Haar NM, Jeyaratnam J, Lachmann HJ et al (2016) The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever registry. Arthritis Rheumatol 68:2795\u20132805. https:\/\/doi.org\/10.1002\/art.39763","journal-title":"Arthritis Rheumatol"},{"key":"6384_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1542\/peds.2012-1372","volume":"133","author":"VS Thors","year":"2014","unstructured":"Thors VS, Vastert SJ, Wulffraat N, van Royen A, Frenkel J, Velden M, de Sain-van der, de Koning TJ (2014) Periodic fever in MVK deficiency: a patient initially diagnosed with incomplete Kawasaki disease. Pediatrics 133:461\u2013465. https:\/\/doi.org\/10.1542\/peds.2012-1372","journal-title":"Pediatrics"},{"key":"6384_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jbspin.2014.12.011","volume":"82","author":"S Berody","year":"2015","unstructured":"Berody S, Galeotti C, Kon\u00e9-Paut I, Piram M (2015) A restrospective survey of patients\u2019s journey before the diagnosis of mevalonate kinase deficiency. Joint Bone Spine 82:240\u2013244. https:\/\/doi.org\/10.1016\/j.jbspin.2014.12.011","journal-title":"Joint Bone Spine"},{"key":"6384_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","volume":"78","author":"Gattorno M, Hofer M, Federici S et al Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO)","year":"2019","unstructured":"Gattorno M, Hofer M, Federici S et al Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) (2019) Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 78:1025\u20131032. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215048","journal-title":"Ann Rheum Dis"},{"key":"6384_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.pcl.2018.04.005","volume":"65","author":"JJY Lee","year":"2018","unstructured":"Lee JJY, Schneider R (2018) Systemic juvenile idiopathic arthritis. Pediatr Clin North Am 65:691\u2013709. https:\/\/doi.org\/10.1016\/j.pcl.2018.04.005","journal-title":"Pediatr Clin North Am"},{"key":"6384_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.hoc.2015.06.010","volume":"29","author":"A Ravelli","year":"2015","unstructured":"Ravelli A, Dav\u00ec S, Minoia F, Martini A, Cron RQ (2015) Macrophage activation syndrome. Hematol Oncol Clin North Am 29:927\u2013941. https:\/\/doi.org\/10.1016\/j.hoc.2015.06.010","journal-title":"Hematol Oncol Clin North Am"},{"key":"6384_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jpeds.2017.06.005","volume":"189","author":"F Minoia","year":"2017","unstructured":"Minoia F, Bovis F, Dav\u00ec S et al (2017) Development and initial validation of the macrophage activation syndrome\/primary hemophagocytic lymphohistiocytosis score, a diagnostic tool that differentiates primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome. J Pediatr 189:72\u201378. https:\/\/doi.org\/10.1016\/j.jpeds.2017.06.005","journal-title":"J Pediatr"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06384-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:13:26Z","timestamp":1672982006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06384-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6384"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06384-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}